| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PRAZOSIN HYDROCHLORIDE | 213052 | 001 | ANDA | PRAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 1MG BASE | No | No | 2023/03/31 | 2023/03/31 | AUROBINDO PHARMA LTD | Prescription |
| PRAZOSIN HYDROCHLORIDE | 213052 | 002 | ANDA | PRAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 2MG BASE | No | No | 2023/03/31 | 2023/03/31 | AUROBINDO PHARMA LTD | Prescription |
| PRAZOSIN HYDROCHLORIDE | 213052 | 003 | ANDA | PRAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 5MG BASE | No | No | 2023/03/31 | 2023/03/31 | AUROBINDO PHARMA LTD | Prescription |
| PRAZOSIN HYDROCHLORIDE | 214083 | 001 | ANDA | PRAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 1MG BASE | No | No | 2024/01/03 | 2024/01/03 | LANNETT CO INC | Discontinued |
| PRAZOSIN HYDROCHLORIDE | 214083 | 002 | ANDA | PRAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 2MG BASE | No | No | 2024/01/03 | 2024/01/03 | LANNETT CO INC | Discontinued |
| PRAZOSIN HYDROCHLORIDE | 214083 | 003 | ANDA | PRAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 5MG BASE | No | No | 2024/01/03 | 2024/01/03 | LANNETT CO INC | Discontinued |
| PRAZOSIN HYDROCHLORIDE | 216727 | 001 | ANDA | PRAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 1MG BASE | No | No | 2024/09/17 | 2024/09/17 | MSN | Prescription |
| PRAZOSIN HYDROCHLORIDE | 216727 | 002 | ANDA | PRAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 2MG BASE | No | No | 2024/09/17 | 2024/09/17 | MSN | Prescription |
| PRAZOSIN HYDROCHLORIDE | 216727 | 003 | ANDA | PRAZOSIN HYDROCHLORIDE | CAPSULE;ORAL | EQ 5MG BASE | No | No | 2024/09/17 | 2024/09/17 | MSN | Prescription |